| KYOWA KIRIN CO. LTD. |
| Japan |
| Gesundheit |
| JP3256000005 / 858523 |
| KY4 (Frankfurt) |
| FRA:KY4, ETR:KY4, KY4:GR |
| Nikkei225 |
| https://www.kyowakirin.co.. |
|
Kyowa Kirin Co., Ltd. is a prominent pharmaceutical company based in Japan, specializing in the research, development, and commercialization of innovative medical treatments. With a strong focus on life sciences, the company is dedicated to addressin..
>Volltext.. |
| 7420.63 Mio. EUR |
| 6386.26 Mio. EUR |
| 2714.93 Mio. EUR |
| 701.75 Mio. EUR |
| 366.34 Mio. EUR |
| 0.7 EUR |
| 142.79 Mio. EUR |
| 1195.47 Mio. EUR |
| 527.98 Mio. EUR |
| 1.21 |
| -11.34% |
| -0.98% |
| 0.33 EUR |
| 2.34% |
| 2.67% |
| 29.12.25 - 0.163275€ 27.06.25 - 0.170928€ >weitere anzeigen... |
| - |
| KYOWA KIRIN |
| 08.04.26 |
|